UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 389, Issue 10066, pp. 299 - 311
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Early Detection of Cancer | Lung Neoplasms - mortality | Humans | Survival Rate | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - therapy | Immunotherapy | Mutation | Lung Neoplasms - diagnosis | Medical colleges | Care and treatment | Lung cancer | Analysis | Oncology, Experimental | Research | Diagnosis | Health aspects | Cancer | Oncology | Medical screening | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 8, pp. 699 - 708
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | General aspects | Tumors of the nervous system. Phacomatoses | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Immunomodulators | Antibodies, Monoclonal, Humanized - adverse effects | Dacarbazine - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Dacarbazine - therapeutic use | Humans | Proportional Hazards Models | Combined Modality Therapy | Brain Neoplasms - drug therapy | Glioblastoma - radiotherapy | Bevacizumab | Disease-Free Survival | Dacarbazine - analogs & derivatives | Survival Analysis | Angiogenesis Inhibitors - therapeutic use | Adult | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Glioblastoma - drug therapy | Angiogenesis Inhibitors - adverse effects | Glioblastoma - mortality | Drug therapy | Glioblastoma multiforme | Research | Nuclear magnetic resonance--NMR | Medical imaging | Glioblastoma | Cognition | Radiation therapy | Cancer therapies | Survival | Patients | Evidence-based medicine | Quality of life | Angiogenesis | Chemotherapy | Intestine | Monoclonal antibodies | Ligands | Death | Temozolomide | Thromboembolism | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 11/2013, Volume 31, Issue 32, pp. 4085 - 4091
Life Sciences & Biomedicine | Oncology | Science & Technology | Neurology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors of the nervous system. Phacomatoses | Tumors | Dacarbazine - administration & dosage | Dacarbazine - adverse effects | Humans | Middle Aged | DNA Repair Enzymes - genetics | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Male | Antineoplastic Agents, Alkylating - administration & dosage | Brain Neoplasms - drug therapy | Chemoradiotherapy | Glioblastoma - radiotherapy | Disease-Free Survival | DNA Methylation | DNA Modification Methylases - genetics | Glioblastoma - genetics | Tumor Suppressor Proteins - genetics | Dacarbazine - analogs & derivatives | Female | Aged | Antineoplastic Agents, Alkylating - adverse effects | Brain Neoplasms - radiotherapy | Glioblastoma - drug therapy | Index Medicus | Original Reports | Neur7 | Neur1
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 14, pp. 1344 - 1355
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Procarbazine - administration & dosage | Astrocytoma - radiotherapy | Oligodendroglioma - mortality | Follow-Up Studies | Humans | Male | Combined Modality Therapy | Brain Neoplasms - drug therapy | Oligodendroglioma - radiotherapy | Young Adult | Disease-Free Survival | Neoplasm Grading | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Astrocytoma - drug therapy | Survival Analysis | Vincristine - administration & dosage | Adult | Female | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Lomustine - administration & dosage | Astrocytoma - mortality | Oligodendroglioma - drug therapy | Procarbazine | Care and treatment | Chemotherapy | Usage | Gliomas | Lomustine | Dosage and administration | Cancer | Brain cancer | Radiation therapy | Oligoastrocytoma | Survival | Patients | Vincristine | Oligodendroglioma | Glioma | Biopsy | Astrocytoma | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Neuro-oncology (Charlottesville, Va.), ISSN 1522-8517, 10/2012, Volume 14, Issue suppl 6, pp. vi25 - vi37
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 8, pp. 783 - 790
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Procarbazine - administration & dosage | Multivariate Analysis | Oligodendroglioma - genetics | Humans | Middle Aged | Brain Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Chemoradiotherapy | Patient Selection | Time Factors | Vincristine - administration & dosage | Female | Brain Neoplasms - mortality | Odds Ratio | Precision Medicine | Oligodendroglioma - mortality | Brain Neoplasms - enzymology | Gene Frequency | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Treatment Outcome | Oligodendroglioma - enzymology | Chi-Square Distribution | Disease Progression | Polymorphism, Genetic | Disease-Free Survival | Oligodendroglioma - therapy | Oligodendroglioma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Brain Neoplasms - therapy | Isocitrate Dehydrogenase - metabolism | Mutation | Lomustine - administration & dosage | Index Medicus | To2 | Neur1 | Neur6 | Original Reports | Neur7 | To22 | Neur8
Journal Article
Nature (London), ISSN 0028-0836, 04/2015, Volume 520, Issue 7546, pp. 224 - 229
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Caudate Nucleus - anatomy & histology | Brain - anatomy & histology | Humans | Middle Aged | Genetic Loci - genetics | Gene Expression Regulation, Developmental - genetics | Apoptosis - genetics | Male | Young Adult | Putamen - anatomy & histology | Aging - genetics | Organ Size - genetics | Aged, 80 and over | Adult | Female | Child | Genome-Wide Association Study | Membrane Proteins - genetics | Sex Characteristics | Magnetic Resonance Imaging | Skull - anatomy & histology | Adolescent | Aged | Genetic Variation - genetics | Hippocampus - anatomy & histology | Genetic research | Brain | Genetic aspects | Brain research | Research | Genetic variation | Genomics | Genomes | Epigenetics | Genes | Index Medicus | Neuroscience | Cognitive science | Medicin och hälsovetenskap
Journal Article